Evidence map›Paper›PMID 41588266›Full record

ReviewCurrent microbiology2026

Microplastic Pollution: Advancements in Mitigation, Policy Challenges, and Future Directions.

Prachi Gaur, Pallavi Gupta, Vivek Gaur, Mika Sillanpa, Rachana Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Prachi GaurAmity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Lucknow, Uttar Pradesh, India.
Pallavi GuptaAmity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Lucknow, Uttar Pradesh, India.
Vivek GaurAmity Institute of Biotechnology, Amity University Uttar Pradesh, Noida,, India.
Mika SillanpaFunctional Materials Group, Gulf University for Science and Technology, Mubarak Al-Abdullah, 32093, Kuwait, Kuwait.
Rachana SinghAmity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Lucknow, Uttar Pradesh, India. rsingh1@lko.amity.edu.ORCID http://orcid.org/0000-0002-4485-752X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microplastic (MPs) pollution has emerged as a significant environmental concern globally, posing threats to ecosystems, human health, and biodiversity. Prior reviews treat biological, engineering, and policy interventions in silos and largely catalog findings without a comparative, decision-oriented synthesis that maps efficacy, limits, scalability, and readiness to concrete deployment contexts. Therefore, this review work provides an integrated, decision-oriented synthesis that jointly evaluates biological, technological, and policy interventions for mitigation. The study finds that filtration is the most deployment-ready option but suffers from fouling and limited capture of the smallest particles, advanced oxidation can work yet is energy- and cost-intensive, while biological/enzymatic routes are promising but slow and scale is limited. Engineered strains can outperform wild types but introduce biosafety and regulatory risks. Looking forward, it emphasizes the necessity for interdisciplinary research and novel technological solutions to address the persistent challenges of MP pollution. The paper concludes with a call for urgent, coordinated action across sectors to develop and implement comprehensive strategies for mitigating this widespread environmental issue.

Indexed as

Environmental PolicyEnvironmental PollutionMicroplasticsEcosystemHumansMicroplastics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.